---
title: "Key facts: AstraZeneca to report Datroway+Imfinzi results; NYSE move"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288924224.md"
description: "AstraZeneca to report late-stage Datroway + Imfinzi lung cancer trial results later this year; continues Datroway studies in earlier-stage breast cancer and highlights patient-selection focus. 1AstraZeneca (AZN) moved its primary listing to the New York Stock Exchange in February. Shares now trade on the NYSE; this was the largest market-capitalization listing transfer in NYSE history. 2"
datetime: "2026-06-06T07:13:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288924224.md)
  - [en](https://longbridge.com/en/news/288924224.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288924224.md)
---

# Key facts: AstraZeneca to report Datroway+Imfinzi results; NYSE move

-   AstraZeneca to report late-stage Datroway + Imfinzi lung cancer trial results later this year; continues Datroway studies in earlier-stage breast cancer and highlights patient-selection focus. 1
-   AstraZeneca (AZN) moved its primary listing to the New York Stock Exchange in February. Shares now trade on the NYSE; this was the largest market-capitalization listing transfer in NYSE history. 2

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)

## Related News & Research

- [PRESS DIGEST-Financial Times - June 9](https://longbridge.com/en/news/289126393.md)
- [AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial](https://longbridge.com/en/news/289098230.md)
- [SkinBioTherapeutics Says Chairman And Non-Exec Director, Both Stepped Down From Board Today](https://longbridge.com/en/news/289012738.md)
- [A new wave of weight-loss therapies aims to be better than today's GLP-1s](https://longbridge.com/en/news/288940300.md)
- [IMF chief warns not to underestimate the backlash against AI's impact on workers](https://longbridge.com/en/news/289214270.md)